These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The two-faced NF-kappaB in the skin. Sur I; Ulvmar M; Toftgård R Int Rev Immunol; 2008; 27(4):205-23. PubMed ID: 18574737 [TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappa B in intestinal protection and destruction. Spehlmann ME; Eckmann L Curr Opin Gastroenterol; 2009 Mar; 25(2):92-9. PubMed ID: 19528876 [TBL] [Abstract][Full Text] [Related]
5. FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB. Lan CC; Yu HS; Wu CS; Kuo HY; Chai CY; Chen GS Br J Dermatol; 2005 Oct; 153(4):725-32. PubMed ID: 16181452 [TBL] [Abstract][Full Text] [Related]
6. Current insights into the regulation of programmed cell death by NF-kappaB. Dutta J; Fan Y; Gupta N; Fan G; Gélinas C Oncogene; 2006 Oct; 25(51):6800-16. PubMed ID: 17072329 [TBL] [Abstract][Full Text] [Related]
7. Turning NF-kappaB and IRFs on and off in DC. Kaisho T; Tanaka T Trends Immunol; 2008 Jul; 29(7):329-36. PubMed ID: 18534908 [TBL] [Abstract][Full Text] [Related]
8. [Cross-talk between nuclear factor-kappaB and P53 signal pathway in keratinocytes after ultraviolet B irradiation]. Wang P; Song XZ; Bi ZG; Xu AE; Cui YG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3088-91. PubMed ID: 18261359 [TBL] [Abstract][Full Text] [Related]
10. Role of nuclear factor-kappaB in the immune system and bone. Jimi E; Ghosh S Immunol Rev; 2005 Dec; 208():80-7. PubMed ID: 16313342 [TBL] [Abstract][Full Text] [Related]
11. UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro. Xia J; Song X; Bi Z; Chu W; Wan Y Int J Mol Med; 2005 Nov; 16(5):943-50. PubMed ID: 16211268 [TBL] [Abstract][Full Text] [Related]
12. [Role of the transcription factor NF-kappaB in the cardiac cell]. Hernández Gutiérrez S; Rojas del Castillo E Arch Cardiol Mex; 2005; 75(3):363-70. PubMed ID: 16294826 [TBL] [Abstract][Full Text] [Related]
13. NF-kappaB and the immune response. Hayden MS; West AP; Ghosh S Oncogene; 2006 Oct; 25(51):6758-80. PubMed ID: 17072327 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of the HaCaT keratinocyte cell line: modulation by adrenomedullin. Pleguezuelos O; Kapas S Br J Dermatol; 2006 Apr; 154(4):602-8. PubMed ID: 16536800 [TBL] [Abstract][Full Text] [Related]
15. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy. Sourbier C; Danilin S; Lindner V; Steger J; Rothhut S; Meyer N; Jacqmin D; Helwig JJ; Lang H; Massfelder T Cancer Res; 2007 Dec; 67(24):11668-76. PubMed ID: 18089796 [TBL] [Abstract][Full Text] [Related]
16. Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms. Pizzi M; Spano P Eur J Pharmacol; 2006 Sep; 545(1):22-8. PubMed ID: 16854410 [TBL] [Abstract][Full Text] [Related]
17. NF-kappaB and inflammation in genetic disease. Sebban H; Courtois G Biochem Pharmacol; 2006 Oct; 72(9):1153-60. PubMed ID: 16965764 [TBL] [Abstract][Full Text] [Related]
18. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target. Yates LL; Górecki DC Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636 [TBL] [Abstract][Full Text] [Related]
19. NF-kappaB and cancer: mechanisms and targets. Karin M Mol Carcinog; 2006 Jun; 45(6):355-61. PubMed ID: 16673382 [TBL] [Abstract][Full Text] [Related]
20. FLIP ing the coin? Death receptor-mediated signals during skin tumorigenesis. Leverkus M; Diessenbacher P; Geserick P Exp Dermatol; 2008 Jul; 17(7):614-22. PubMed ID: 18558995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]